L.E.A.F. Pharmaceuticals Receives Positive US FDA Feedback and...
VALLEY FORGE, Pennsylvania, Oct. 30, 2018 /PRNewswire-AsiaNet/ -- -- US FDA further indicates that one of the four drugs may be eligible for registration via 505(b)(2) Regulatory PathwayL.E.A.F. Pharmaceuticals LLC (http://www.leafpharmaceuticals.com/ ) ("LEAF"), a global pharmaceutical company focused on de...
Read more https://view-release/?pr-id=76016